Estimating the transfusion risk following total knee arthroplasty. （開啟新視窗）

Ahmed I, Chan JK, Jenkins P, Brenkel I, Walmsley P.

出處‎: Orthopedics 2012;35(10):e1465-71.

檢索‎: PubMed 23027481

DOI碼‎: 10.3928/01477447-20120919-13

https://www.ncbi.nlm.nih.gov/pubmed/23027481 （開啟新視窗）

Ginkgo biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication. （開啟新視窗）

Bebbington A, Kulkarni R, Roberts P.

出處‎: J Arthroplasty 2005;20(1):125-6.

檢索‎: PubMed 15660071

DOI碼‎: 10.1016/j.arth.2004.02.031

https://www.ncbi.nlm.nih.gov/pubmed/15660071 （開啟新視窗）

Factors affecting transfusion requirement after hip fracture: can we reduce the need for blood? （開啟新視窗）

Desai SJ, Wood KS, Marsh J, Bryant D, Abdo H, Lawendy AR, Sanders DW.

出處‎: Can J Surg 2014;57(5):342-8.

檢索‎: PubMed 25265109

https://www.ncbi.nlm.nih.gov/pubmed/25265109 （開啟新視窗）

Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. （開啟新視窗）

Walsh TS, Palmer J, Watson D, Biggin K, Seretny M, Davidson H, Harkness M, Hay A.

出處‎: Br J Anaesth 2012;108(1):63-71.

檢索‎: PubMed 22037224

DOI碼‎: 10.1093/bja/aer326

https://www.ncbi.nlm.nih.gov/pubmed/22037224 （開啟新視窗）